High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study

被引：22
|
作者：
Reyes, Henry D. [1 ]
Miecznikowski, Jeffrey [2 ]
Gonzalez-Bosquet, Jesus [1 ]
Devor, Eric J. [1 ]
Zhang, Yuping [1 ]
Thiel, Kristina W. [1 ]
Samuelson, Megan I. [3 ]
McDonald, Megan [1 ]
Stephan, Jean-Marie [1 ]
Hanjani, Parviz [4 ]
Guntupalli, Saketh [5 ]
Tewari, Krishnansu S. [6 ]
Backes, Floor [7 ]
Ramirez, Nilsa [8 ]
Fleming, Gini F. [9 ]
Filiaci, Virginia [10 ]
Birrer, Michael J. [11 ]
Leslie, Kimberly K. [1 ]
机构：
[1] Univ Iowa, Holden Comprehens Canc Ctr, Dept Obstet & Gynecol, Iowa City, IA 52242 USA
[2] SUNY Univ Buffalo, Dept Biostat, Buffalo, NY USA
[3] Univ Iowa, Holden Comprehens Canc Ctr, Dept Pathol, Iowa City, IA 52242 USA
[4] Abington Mem Hosp, Dept Gynecol Oncol, Hanjani Inst Gynecol Oncol, Abington, PA 19001 USA
[5] Univ Colorado Denver, Dept Obstet & Gynecol, Aurora, CO USA
[6] Univ Calif Irvine, Med Ctr, Div Gynecol Oncol, Orange, CA USA
[7] Ohio State Univ, Med Ctr, Dept Div Obstet & Gynecol, Columbus, OH 43210 USA
[8] Nationwide Childrens Hosp, Res Inst, Dept Pathol, Columbus, OH USA
[9] Univ Chicago, Sect Med Oncol, Chicago, IL 60637 USA
[10] Roswell Pk Canc Inst, NRG Oncol, Gynecol Oncol Grp, Biostat & Data Ctr, Buffalo, NY 14263 USA
[11] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 146卷 / 02期
关键词：
PHASE-III TRIAL; OVEREXPRESSION; CARCINOMA; CHEMOTHERAPY; PROGNOSIS; PROLIFERATION; METASTASIS; MIGRATION; SUGGESTS; TUMORS;
D O I：
10.1016/j.ygyno.2017.05.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objective. Gynecologic Oncology Group (GOG) 177 demonstrated that addition of paclitaxel to a backbone of adriamycin/cisplatin improves overall survival (OS) and progression-free survival (PFS) for patients with advanced or recurrent endometrial cancer. Using patient specimens from GOG-177, our objective was to identify potential mechanisms underlying the improved clinical response to taxanes. Stathmin (STMN1) is a recognized poor prognostic marker in endometrial cancer that functions as a microtubule depolymerizing protein, allowing
引用
收藏
页码：247 / 253
页数：7
相关论文
共 50 条
  • [31] Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study
    Alberts, David S.
    Garcia, Franciso A. R.
    Trimble, Cornelia L.
    Kauderer, James
    Curtin, John
    Lim, Peter C.
    Hess, Lisa M.
    Silverberg, Steven
    Zaino, Richard J.
    Yozwiak, Michael
    Bartels, Hubert G.
    Bartels, Peter
    CANCER RESEARCH, 2012, 72
  • [32] The History of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG)
    Onda, Takashi
    Konishi, Ikuo
    Yoshikawa, Hiroyuki
    Kamura, Toshiharu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (10) : 1156 - 1161
  • [33] Physical Activity Levels Among Ovarian Cancer Survivors: An NRG Oncology/Gynecologic Group Study
    Garcia, David O.
    Crane, Tracy
    Basen-Engquist, Karen
    Alberts, David
    Hartz, Vern
    Kendrick, James E.
    Mannel, Robert S.
    Van Le, Linda
    DiSilvestro, Paul
    Schnell, Frederick
    Thomson, Cynthia A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2015, 47 (05): : 626 - 626
  • [34] Synuclein-γ in Uterine Serous Carcinoma Impacts Survival: An NRG Oncology/Gynecologic Oncology Group Study
    Winder, Abigail D.
    Maniar, Kruti P.
    Wei, Jian-Jun
    Liu, Dachao
    Scholtens, Denise M.
    Lurain, John R.
    Schink, Julian C.
    Buttin, Barbara M.
    Filiaci, Virginia L.
    Lankes, Heather A.
    Ramirez, Nilsa C.
    Park, Kay
    Singh, Meenakshi
    Lieberman, Richard W.
    Mannel, Robert S.
    Powell, Matthew A.
    Backes, Floor J.
    Mathews, Cara A.
    Pearl, Michael L.
    Secord, Angeles Alvarez
    Peace, David J.
    Mutch, David G.
    Creasman, William T.
    Kim, J. Julie
    CANCER, 2017, 123 (07) : 1144 - 1155
  • [35] A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study*
    Burton, Elizabeth R.
    Brady, Mark
    Homesley, Howard D.
    Rose, Peter G.
    Nakamura, Toshiaki
    Kesterson, Joshua P.
    Rotmensch, Jacob
    Thigpen, J. Tate
    Van Le, Linda
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 48 - 52
  • [36] Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study
    Devor, Eric J.
    Miecznikowski, Jeffrey
    Schickling, Brandon M.
    Gonzalez-Bosquet, Jesus
    Lankes, Heather A.
    Thaker, Premal
    Argenta, Peter A.
    Pearl, Michael L.
    Zweizig, Susan L.
    Mannel, Robert S.
    Brown, Amy
    Ramirez, Nilsa C.
    Ioffe, Olga B.
    Park, Kay J.
    Creasman, William T.
    Birrer, Michael J.
    Mutch, David
    Leslie, Kimberly K.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (03) : 648 - 653
  • [37] Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
    Burger, Robert A.
    Deng, Wei
    Makker, Vicky
    Collins, Yvonne
    Gray, Heidi
    Debernardo, Robert
    Martin, Lainie P.
    Aghajanian, Carol
    GYNECOLOGIC ONCOLOGY, 2018, 150 (03) : 466 - 470
  • [38] Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study
    von Gruenigen, Vivian E.
    Huang, Helen Q.
    Beumer, Jan H.
    Lankes, Heather A.
    Tew, William
    Herzog, Thomas
    Hurria, Arti
    Mannel, Robert S.
    Rizack, Tina
    Landrum, Lisa M.
    Rose, Peter G.
    Salani, Ritu
    Bradley, William H.
    Rutherford, Thomas J.
    Higgins, Robert V.
    Secord, Angeles Alvarez
    Fleming, Gini
    GYNECOLOGIC ONCOLOGY, 2017, 144 (03) : 459 - 467
  • [39] Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
    Lee, Jung-Yun
    Kim, Kidong
    Lee, Taek Sang
    Kang, Sokbom
    Seong, Seok Ju
    Kim, Jae Weon
    Kim, Byoung-Gie
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (04) : 277 - 283
  • [40] Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)
    Tewari, Krishnansu S.
    Sill, Michael W.
    Monk, Bradley J.
    Penson, Richard T.
    Moore, David H.
    Lankes, Heather A.
    Ramondetta, Lois M.
    Landrum, Lisa M.
    Randall, Leslie M.
    Oaknin, Ana
    Leitao, Mario M.
    Eisenhauer, Eric L.
    DiSilvestro, Paul
    Van Le, Linda
    Pearl, Michael L.
    Burke, James J.
    Salani, Ritu
    Richardson, Debra L.
    Michael, Helen E.
    Kindelberger, David W.
    Birrer, Michael J.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2363 - 2370
12345